Table 4.
Level of vaccination, vaccine breakthrough infection rate, and adverse events by vaccine type, national vaccine coverage survey, Egypt, March–May 2022
| Level of vaccination | Total vaccinated (n = 8,742) | Inactivated (n = 3,530) | Viral vector (n = 3,015) | mRNA (2,142) | Heterologous (n = 55) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number | Percent | Number | Percent | Number | Percent | Number | Percent | Number | Percent | |
| Full vaccination | 7567 | 86.6% | 3122 | 88.4% | 2576 | 85.4% | 1854 | 86.6% | 15 | 27.3% |
| Booster | 453 | 5.2% | 224 | 6.3% | 142 | 4.7% | 47 | 2.2% | 40 | 72.7% |
| Partial vaccination | 722 | 8.3% | 184 | 5.2% | 297 | 9.9% | 241 | 11.3% | 0 | 0.0% |
| Vaccine breakthrough | 117 | 1.3% | 55 | 1.6% | 42 | 1.4% | 19 | 0.9% | 0 | 0.0% |
| Adverse events | 3618 | 41.4% | 1129 | 32.0% | 1391 | 46.1% | 1074 | 50.1% | 24 | 43.6% |